NeuroPace, Inc. operates as a medical device company in the United States. It develops and sells RNS system, a brain-responsive neuromodulation system that delivers personalized real-time treatment.
At the seizure source for treating medically refractory focal epilepsy. The company’s RNS system also records continuous brain activity data and enables clinicians to monitor patients in person and remotely.
